- PROCTO3 REPORT AT Gastroenterology, Hepatobiliary, and Biliary Department - FV HOSPITAL (17/01/2024 )
- GLIGCA REPORT AT SPINE DEPARTMENT B – HCMC ORTHOPEDIC TRAUMA HOSPITAL (17/01/2024 )
- REPORT TAMDEFLO, CAPSER, VOCFOR, DEGODAS CAN THO CENTRAL GERD (17/01/2024 )
- REPORT TAMDEFLO ORTHOPEDIC TRAUMA DEPARTMENT (17/01/2024 )
- CAPSER REPORT FOR MUSCULOSCOPIC AND JOINT DEPARTMENT OF CHO RAY HOSPITAL (17/01/2024 )
- Report TAMDEFLO Thong Nhat Hospital (17/01/2024 )
- Report TAMDEFLO MEDIC BINH DUONG (17/01/2024 )
- GLIGCA REPORT AT THE PHARMACY DEPARTMENT - FV HOSPITAL (11/01/2024 )
- CAPSER – ENDOCRINE DEPARTMENT, CHO RAY HOSPITAL (16/10/2023 )
- Report CAPSER, DEGODAS – JOINT DEPARTMENT OF ORTHOPEDIC TRAUMA HOSPITAL (16/10/2023 )
TAMDEFLO MINH DUC HOSPITALOn October 21, 2023, Medbolide Joint Stock Company had a report to introduce the product TAMDEFLO (deflazacort 6mg) at the hall of Minh Duc Hospital, Ben Tre. The report took place with the participation of more than 30 Doc
On October 21, 2023, Medbolide Joint Stock Company had a report to introduce the product TAMDEFLO (deflazacort 6mg) at the hall of Minh Duc Hospital, Ben Tre.
The report took place with the participation of more than 30 Doctors and medical staff.
Report session with the topic: "Deflazacort - New generation Corticoids". Company representatives presented recommendations and clinical research demonstrating the effectiveness of the active ingredient deflazacort and the product's outstanding advantage of limiting typical side effects of corticosteroids.
After the report, the doctors had many discussions about the use and safety of the drug.
At the end of the report, Medbolide Company sends its thanks and hopes to continue accompanying the Hospital in bringing solutions to improve the quality of life for patients.
Readers comments